Dunbar, C., Chang, L., Mullen, C., Ramsey, W. J., Carter, C., Kohn, D., … Hershfield, M. S. (1999). Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene. Hum Gene Ther, 10(3), 477–488. https://doi.org/10.1089/10430349950018913

Dunbar, C., L. Chang, C. Mullen, W. J. Ramsey, C. Carter, D. Kohn, R. Parkman, et al. “Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.” Hum Gene Ther 10, no. 3 (February 10, 1999): 477–88. https://doi.org/10.1089/10430349950018913.

Dunbar C, Chang L, Mullen C, Ramsey WJ, Carter C, Kohn D, et al. Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene. Hum Gene Ther. 1999 Feb 10;10(3):477–88.

Dunbar, C., et al. “Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.” Hum Gene Ther, vol. 10, no. 3, Feb. 1999, pp. 477–88. Pubmed, doi:10.1089/10430349950018913.

Dunbar C, Chang L, Mullen C, Ramsey WJ, Carter C, Kohn D, Parkman R, Lenarsky C, Weinberg K, Wara D, Culver KW, Anderson WF, Leitman S, Fleisher T, Klein H, Shearer G, Clerici M, McGarrity G, Bastian J, Hershfield MS. Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene. Hum Gene Ther. 1999 Feb 10;10(3):477–488.